P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES... by H. Einsele, B. Dhakal, J. M. Schecter, T. Roccia, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, K. Connors, K. Qi, A. Londhe, R. Carson, J. Voelker, P. Cost, S. Valluri, E. Florendo, L. Pacaud, K. Yong

Get full text